5mg dispense of the pALD-CV77 Luciferase reporter plasmid. Consistent with the pALD-CV77 cloning backbone, Aldevron offers a pre-made reporter construct, pALD-CV77-Luciferase, which has several advantages:
Commercially available sequence for research through clinical use
Kanamycin resistance
Consistent, reliable supply
Immediately available at research grade
This product is subject to the following: Limited Use License